Iturin: A Promising Cyclic Lipopeptide with Diverse Applications

Biomolecules. 2023 Oct 12;13(10):1515. doi: 10.3390/biom13101515.

Abstract

This comprehensive review examines iturin, a cyclic lipopeptide originating from Bacillus subtilis and related bacteria. These compounds are structurally diverse and possess potent inhibitory effects against plant disease-causing bacteria and fungi. Notably, Iturin A exhibits strong antifungal properties and low toxicity, making it valuable for bio-pesticides and mycosis treatment. Emerging research reveals additional capabilities, including anticancer and hemolytic features. Iturin finds applications across industries. In food, iturin as a biosurfactant serves beyond surface tension reduction, enhancing emulsions and texture. Biosurfactants are significant in soil remediation, agriculture, wound healing, and sustainability. They also show promise in Microbial Enhanced Oil Recovery (MEOR) in the petroleum industry. The pharmaceutical and cosmetic industries recognize iturin's diverse properties, such as antibacterial, antifungal, antiviral, anticancer, and anti-obesity effects. Cosmetic applications span emulsification, anti-wrinkle, and antibacterial use. Understanding iturin's structure, synthesis, and applications gains importance as biosurfactant and lipopeptide research advances. This review focuses on emphasizing iturin's structural characteristics, production methods, biological effects, and applications across industries. It probes iturin's antibacterial, antifungal potential, antiviral efficacy, and cancer treatment capabilities. It explores diverse applications in food, petroleum, pharmaceuticals, and cosmetics, considering recent developments, challenges, and prospects.

Keywords: applications; biological activity; in silico studies; iturin; production.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents
  • Antifungal Agents* / chemistry
  • Antifungal Agents* / pharmacology
  • Antiviral Agents
  • Bacillus subtilis*
  • Lipopeptides

Substances

  • Antifungal Agents
  • Lipopeptides
  • Anti-Bacterial Agents
  • Antiviral Agents

Grants and funding

This research received no external funding.